The world cancer immunotherapy market is expected to grow at a CAGR of 11.4%

Tuesday, March 5, 2019 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 4, 2019 /PRNewswire/ -- Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics

Read the full report: https://www.reportlinker.com/p05748384 The world cancer immunotherapy market is expected to grow at a CAGR of 11.4% in the second half of the forecast period. The market reached $63bn in
2018, dominated by the monoclonal antibody segment which held 66% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 194-page report you will receive 110 tables and 93 figures– all unavailable elsewhere.The 194-page report provides clear detailed insight into the global cancer-treating drugs market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• Global cancer immunotherapy market forecasts from 2019-2029This report also breaks down the revenue forecast for the global cancer immunotherapy market by Technology:• Monoclonal Antibodies• Cytokines & immunomodulators• Others (Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy)Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.This report also breaks down the revenue forecast for the global cancer immunotherapy market by Application:• Lung Cancer• Breast Cancer• Colorectal cancer• Melanoma Cancer• Prostate Cancer• Head & Neck Cancer,• Others (Renal Cell Carcinoma, Cervical, Gastric, Lymphoma)Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.This report also breaks down the revenue forecast for the world cancer immunotherapy market by End-User:• Hospitals• Cancer Research Centers• ClinicsEach submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.This report provides individual revenue forecasts to 2029 for these regional and national markets:North America: US, Canada, MexicoSouth America: Brazil, Argentina, Paraguay, Bolivia, Rest of South AmericaEurope: The UK, Germany, France, Spain, Italy, Rest of EuropeAsia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific• Rest of World: Middle East, Africa, Other CountriesEach regional market is further broken down by technology, application and end-user.• This report discusses trends in the industry and assesses drivers and restraints, as well as opportunities and threats. It also includes porters' five force analysis; threat of new entrants, power of suppliers, power of buyers, rivalry among competitors and threat of substituents.Our study discusses the selected leading companies that are the major players in the cancer immunotherapy market:• Adaxic Inc• AstraZeneca• Bayer• Bristol-Myers Squibb (BMS)• Eli Lilly and Co.• Medtronic Plc• Merck & Co., Inc. (Merck)• Novartis• Pfizer• RocheThe report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.Read the full report: https://www.reportlinker.com/p05748384 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-world-cancer-immunotherapy-market-is-expected-to-grow-at-a-cagr-of-11-4-300806012.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store